The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation
Abstract
BACKGROUND AND PURPOSE: MR perfusion has shown abnormalities of affected WM in cerebral X-linked adrenoleukodystrophy, but serial data is needed to explore the import of such findings after hematopoietic stem cell transplantation. Our aim was to prospectively measure MR perfusion parameters in patients with cerebral adrenoleukodystrophy pre- and post-hematopoietic stem cell transplantation, and to correlate those measurements with clinical outcome. MATERIALS AND METHODS: Ten patients with cerebral adrenoleukodystrophy prospectively underwent DSC-MR perfusion imaging at <45 days pre- (baseline), 30-60 days post-, and 1 year post-hematopoietic stem cell transplantation. MR perfusion measurements in the 10 patients and 8 controls were obtained from the parieto-occipital WM, splenium of the corpus callosum, leading enhancing edge, and normal-appearing frontal white matter. MR imaging severity scores and clinical neurologic function and neurocognitive scores were also obtained. MR perfusion values were analyzed in the patients with cerebral adrenoleukodystrophy at each time point and compared with those in controls. Correlations were calculated between the pre-hematopoietic stem cell transplantation MR perfusion values and 1-year clinical scores, with P value adjustment for multiple comparisons. RESULTS: At baseline in patients with cerebral adrenoleukodystrophy, both relative CBV and relative CBF within the splenium of the corpus callosum and parieto-occipital WM significantly differed from those in controls (P = .005-.031) and remained so 1 year post-hematopoietic stem cell transplantation (P = .003-.005). Meanwhile, no MR perfusion parameter within the leading enhancing edge differed significantly from that in controls at baseline or at 1 year (P = .074-.999) or significantly changed by 1 year post-hematopoietic stem cell transplantation (P = .142-.887). Baseline Loes scores correlated with 1-year clinical neurologic function (r = 0.813, P < .0001), while splenium of the corpus callosum relative CBV also significantly correlated with 1-year neurologic function scale and the neurocognitive full-scale intelligence quotient and performance intelligence quotient scores (r = -0.730-0.815, P = .007-.038). CONCLUSIONS: Leading enhancing edge measurements likely remain normal post-hematopoietic stem cell transplantation in cerebral adrenoleukodystrophy, suggesting local disease stabilization. Meanwhile, parieto-occipital WM and splenium of the corpus callosum relative CBV and relative CBF values worsened; this change signified irreversible injury. Baseline splenium of the corpus callosum relative CBV may predict clinical outcomes following hematopoietic stem cell transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, regional increases in these flow disturbances precede progression of the active demyelination5,9–11.”
From Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Indeed, dynamic susceptibility contrast MR (DSC-MR) perfusion studies in ALD patients have shown that ABCD1 dysfunction alters white matter capillary flow and limits the metabolic rate of oxygen.”
From Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 5×
“Such an arrest in demyelination may have a histopathologic precedent, in which murine studies have shown that certain microglial cells are absent initially at the demyelinating edge, but there is a subsequent slow return of microglial guard cells by about 1 year post-HSCT as progression of the disease halts.(22-26) Th…”
BackgroundResultInfluentialMildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445
Shapiro, E., Krivit, W., Lockman, L., Jambaqué, I., Peters, C., Cowan, M., Harris, R., Blanche, S., Bordigoni, P., Loes, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02629-5 · Cited by 329
Self-citationMiller, W. P., Rothman, S. M., Nascene, D., Kivisto, T., DeFor, T. E., Ziegler, R. S., Eisengart, J., Leiser, K., Raymond, G., Lund, T. C., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329235 · Cited by 290
Self-citation
Research works printed but not linked: 23
- Moser HW , Smith KD , Watkins PA , et al . X-linked adrenoleukodystrophy. In: Scriver CR , Beaudet AL , Sly WS , et al , eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:3257–301
- 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L · DOI
- Melhem, 2000, X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression, AJNR Am J Neuroradiol, 21, 839
- Schaumburg, 1975, Adrenoleukodystrophy: a clinical and pathological study of 17 cases, Arch Neurol, 33, 577, 10.1001/archneur.1975.00490510033001 · DOI · Paper page
- 10.1097/01.jnen.0000190064.28559.a4 · DOI
- 10.1182/blood-2003-10-3402 · DOI · Paper page
- Loes, 1994, Adrenoleukodystrophy: a scoring method for brain MR observations, AJNR Am J Neuroradiol, 15, 1761
- 10.1007/978-1-4419-9072-3-47 · DOI
- 10.1212/01.WNL.0000079050.91337.83 · DOI · Paper page
- 10.1093/brain/aws206 · DOI · Paper page
- 10.1148/radiol.2232010673 · DOI
- 10.3174/ajnr.A0484 · DOI
- 10.1148/radiology.211.3.r99jn46791 · DOI
- 10.1148/radiol.2243011014 · DOI
- Brubaker, 2005, Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging, AJNR Am J Neuroradiol, 26, 825
- Boxerman, 2006, Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not, AJNR Am J Neuroradiol, 27, 859
- 10.3174/ajnr.A3232 · DOI
- Wechsler D . Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). San Antonio: Psychological Corporation; 2003 · DOI · Paper page
- 10.1212/WNL.54.8.1651 · DOI
- 10.1111/j.1750-3639.2010.00394.x · DOI · Paper page
- 10.1002/ana.21391 · DOI · Paper page
- Kennedy, 1997, Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model, Blood, 9, 986, 10.1182/blood.V90.3.986 · DOI
- 10.3174/ajnr.A4500 · DOI
Cited by
ABCD1 dysfunction alters white matter microvascular perfusion
Lauer, A., Da, X., Hansen, M. B., Boulouis, G., Ou, Y., Cai, X., Liberato Celso Pedrotti, A., Kalpathy-Cramer, J., Caruso, P., Hayden, D. L., et al. (2017) · Brain · doi:10.1093/brain/awx262 · Cited by 48
Lauer, A., Speroni, S. L., Choi, M., Da, X., Duncan, C., McCarthy, S., Krishnan, V., Lusk, C. A., Rohde, D., Hansen, M. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37262-w · Cited by 26
Self-citation
Metadata
- Authors
- McKinney, A. M., Benson, J., Nascene, D. R., Eisengart, J., Salmela, M. B., Loes, D. J., Zhang, L., Patel, K., Raymond, G. V., & Miller, W. P.
- ORCID
- Venue
- American Journal of Neuroradiology
- Published
- 2016-04-14
- Volume
- 37
- Issue
- 9
- Pages
- 1713-1720
- ISSN
- 0195-6108
- 1936-959X
- PMC
- PMC5018408
- Cited by
- 12
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
